NFLX vs XERS · P/E 25, rev $12.56B vs rev $175.2M
Netflix Inc (NFLX) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
NFLX currently screens at market cap $324.06B and trailing P/E 24.8. XERS currently screens at market cap $760.7M.
Not investment advice. Open the NFLX and XERS stock pages for the full models.
Not investment advice.